$ADMP Zimhi PDUFA date is now officially a month away. I have a high conviction that Zimhi will be approved this time. I also believe Tempol phase I trial is close to the finish line in terms of dosing ! November could be the biggest month in the history of this co. Tempol is safe, but the efficacy is yet to be proven. We are now entering into the high-volume period with unusual volatility. We will know soon one way or the other. This will be a lot of fun, but always keep in mind the other side of the equation - ‘risk’. Being a small cap penny stock, potentially developing a Covid oral pill, this will attract a lot investor attention.